Get started
Author

Mai Nagasaka

Insights into Regulators of p53 Acetylation
2022 · Mai Nagasaka, Chiharu Miyajima, et al. · Cells · 45
PDF
Anti-Tumorigenic Activity of Chrysin from Oroxylum indicum via Non-Genotoxic p53 Activation through the ATM-Chk2 Pathway
2018 · Mai Nagasaka, Ryoko Hashimoto, et al. · Molecules · 45
PDF
The CDK inhibitor p21 is a novel target gene of ATF 4 and contributes to cell survival under ER stress
2017 · Yasumichi Inoue, Shiori Kawachi, et al. · FEBS Letters · 44
PDF
Negative Regulation of Neuromedin U mRNA Expression in the Rat Pars Tuberalis by Melatonin
2013 · Sayaka Aizawa, Ichiro Sakata, et al. · PLoS ONE · 23
PDF
Lysine-Specific Demethylase 1 (LSD1/KDM1A) Is a Novel Target Gene of c-Myc
2019 · Mai Nagasaka, Kaori Tsuzuki, et al. · Biological and Pharmaceutical Bulletin · 19
PDF
HMG-CoA Reductase Inhibitor Statins Activate the Transcriptional Activity of p53 by Regulating the Expression of TAZ
2022 · Chiharu Miyajima, Yurika Hayakawa, et al. · Pharmaceuticals · 17
PDF
The deubiquitinating enzyme USP17 regulates c‐Myc levels and controls cell proliferation and glycolysis
2022 · Mai Nagasaka, Yasumichi Inoue, et al. · FEBS Letters · 17
The Hippo Signaling Pathway Manipulates Cellular Senescence
2024 · Chiharu Miyajima, Mai Nagasaka, et al. · Cells · 9
PDF
ID3 is a novel target gene of p53 and modulates lung cancer cell metastasis
2024 · Mai Nagasaka, Chiharu Miyajima, et al. · Biochemical and Biophysical Research Communications · 5
Pharmacologic inhibition of BMI1 exerts antitumor effects against MYCN-amplified neuroblastoma, with activation of the p53 pathway
2025 · Masahiro Hirayama, Eri Yamada, et al. · Scientific Reports · 3
PDF
The novel ALK K1150dup mutation mediates resistance to frontline lorlatinib and retains sensitivity to gilteritinib
2026 · Mai Nagasaka, Francesco Facchinetti, et al. · npj Precision Oncology · 2
PDF
SET8 is a novel negative regulator of TGF-β signaling in a methylation-independent manner
2023 · Mai Nagasaka, Yasumichi Inoue, et al. · Scientific Reports · 1
PDF
BMF deficiency promotes drug-tolerant persister cell formation in ALK/ROS1-positive lung cancer
2026 · Takahiro Utsumi, Mai Nagasaka, et al. · Cell Death and Disease
PDF
Bidirectional Regulation of c-Myc and TRB1 Establishes Oncogenic Reciprocal Regulation
2026 · Yuya Suzuki, Mai Nagasaka, et al. · Biological and Pharmaceutical Bulletin
PDF
Combination of CHK1 and CHK2 inhibitors exerts synergistic antitumor effects against neuroblastoma cells
2026 · Rina Kato, Hiromasa Aoki, et al. · Pediatric Research
Abstract 395: Identification of drug resistance factors in ALK-rearranged lung cancer using genome-wide CRISPR activation screening.
2026 · Mai Nagasaka, Marie Kawahara, et al. · Cancer Research
Works count: 16
Citation count: 230
H-index: 8
I10-index: 7
Year
Topic
Type